
Bioorganic and Medicinal Chemistry Letters p. 2651 - 2656 (1997)
Update date:2022-09-26
Topics:
Yang, Xian-Bin
Misiura, Konrad
Sochacki, Marek
Stec, Wojciech J.
New reagent, 5'-O-DMT-xylothymidine 3'-O-(2-thio-4,4-spiropentamethylene-1,3,2-oxathiaphospholane) and its separated diastereomers can be used for stereocontrolled incorporation of xylothymidine 3'-O-phosphorothioate of predetermined sense of P-chirality into desired oligonucleotide constructs.
View MoreShenzhen Feiming Science and Technology Co,. Ltd
Contact:+86-755-85232577
Address:#B2309, Fenglin International Center ,Jixiang Road, Longcheng street, LongGang District, Shenzhen city, Guangdong province, China.
Tianjin Crest Pharmaceutical R&D Co., Ltd. (Tianjin Yao Technology Development Co., Ltd.)(expird)
Contact:+86-22-66211386
Address:Building B5-405, No, 80 4th Avenue, TEDA, Tianjin, China P.R. 300457
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:No.199, Ningbo Avenue, Fengxin industrial park, Fengxin county, Yichun city, Jiangxi
HangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Contact:13357117572
Address:No.149 Shiji dadao Road.
Doi:10.1039/c7cc03241b
(2017)Doi:10.1002/ejoc.200900407
(2009)Doi:10.14233/ajchem.2013.13227
(2013)Doi:10.1016/j.bmcl.2004.07.001
(2004)Doi:10.1016/S0040-4039(00)94492-7
(1990)Doi:10.1016/S0040-4020(97)10292-7
(1998)